Zenan Gu
Papers
1
Total Citations
6
H-Index
1
About
Zenan Gu is an emerging surgical oncologist whose research focuses on minimally invasive thoracic surgery, particularly the comparative outcomes of robotic-assisted and thoracoscopic approaches in the treatment of non-small cell lung cancer (NSCLC). Working from a high-volume clinical center, Gu has contributed meaningful real-world evidence to one of the most pressing questions in modern thoracic surgery: whether robotic lobectomy offers tangible advantages over conventional thoracoscopic techniques in oncologically complex cases. His most recognized work, published in 2024, examines lymph node dissection quality and early recurrence rates in stage N1-2 NSCLC patients over an impressive eleven-year dataset, providing the kind of longitudinal, real-world insight that prospective trials often struggle to capture. With 6 citations already accrued shortly after publication, the study is gaining traction among surgeons and oncologists navigating treatment decisions for locally advanced lung cancer. Gu's research sits at a critical intersection of surgical technique, oncological outcomes, and technology adoption, making his work particularly relevant for clinicians seeking evidence-based guidance in an era of rapidly evolving robotic surgical platforms.
Research Focus
Key Achievements
Top Papers
- 1